<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01538992</url>
  </required_header>
  <id_info>
    <org_study_id>Bursa YİEAH</org_study_id>
    <nct_id>NCT01538992</nct_id>
  </id_info>
  <brief_title>Renal Denervation in Patients With Advanced Heart Failure</brief_title>
  <official_title>Phase 3 Study of Renal Denervation That Improves Symptoms of Heart Failure and Enhances Life Quality in Advanced Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bursa Postgraduate Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bursa Postgraduate Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sympathetic system has important role occurrence of symptoms in heart failure. Renal
      denervation that is ablated some of sympathetic nerves is affected pathology of heart
      failure. This interventional therapy improves symptoms and life quality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Primary Outcome Measures:

      • Safety of Renal Denervation in Heart Failure patients as measured by Adverse Events

      Secondary Outcome Measures:

      • Ventricular function,NYHA functional Class, 6 min walking test, biochemical test and Renal
      function as measured by Glomerular Filtration Rate (GFR)

      Eligibility Patients population: Volunteers, NYHA Class III-IV heart failure patients. Ages
      Eligible for Study: 18 Years to 85 Years Genders Eligible for Study: Both Accepts Healthy
      Volunteers: No
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    we could not fined enough patients for the study
  </why_stopped>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety of Renal Denervation in Heart Failure patients as measured by Adverse Events</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>• Ventricular function as measured by Echocardiography • NYHA functional Class, 6 min walking test, biochemical test. • Renal function as measured by Glomerular Filtration Rate (GFR)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>renal denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>in this group percutaneous renal denervation with Standard steerable Mariner Radiofreqency ablation Catheter (5F or 7F)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>medical thrapy</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>medical treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard steerable Marinr RF ablation Catheter (5F or 7F)</intervention_name>
    <description>Intervention: Device: Standard steerable Mariner Radiofrequency ablation Catheter (5F or 7F)</description>
    <arm_group_label>renal denervation</arm_group_label>
    <other_name>Renal ablation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart Failure patients NYHA Class III or IV

          -  Left Ventricular Ejection Function &lt; 35%

          -  GFR &gt; 45 mL/min/1.73m2

          -  Optimal stable medical therapy

        Exclusion Criteria:

          -  Do not eligible renal artery anatomy for treatment as determined by Angiography, and

          -  History of prior renal artery intervention

          -  Single functioning kidney.

          -  Myocardial Infarction, unstable angina pectoris or cerebrovascular Accident within 3
             months

          -  Systolic BP &lt; 110mmHG Hospitalisation because of heart failure in last 3 weeks.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>HASAN ARI, MD</last_name>
    <role>Study Director</role>
    <affiliation>Bursa Postgraduate Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi</name>
      <address>
        <city>Bursa</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2012</study_first_submitted>
  <study_first_submitted_qc>February 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 27, 2012</study_first_posted>
  <last_update_submitted>July 23, 2013</last_update_submitted>
  <last_update_submitted_qc>July 23, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bursa Postgraduate Hospital</investigator_affiliation>
    <investigator_full_name>Hasan ARI</investigator_full_name>
    <investigator_title>Medical Doctor, Cardiology Chief Intern</investigator_title>
  </responsible_party>
  <keyword>renal denervation</keyword>
  <keyword>heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

